Registry of Lobbyists

Advanced Registry Search Results

Registration (17)
Results: 1-17 | Export
  1. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Sridhar Venkatesh, General Manager and President
    Registration: 63 of 63 (2024-04-01 to present)
    Posted: 2024-05-03
    Subject matter details: 18
    Government institutions: 18
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 10
  2. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Sridhar Venkatesh, General Manager and President
    Registration: 62 of 63 (2024-03-15 to 2024-04-01)
    Posted: 2024-03-15
    Subject matter details: 18
    Government institutions: 18
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 10
  3. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Sridhar Venkatesh, General Manager and President
    Registration: 61 of 63 (2024-02-13 to 2024-03-15)
    Posted: 2024-02-16
    Subject matter details: 18
    Government institutions: 17
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 10
  4. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Sridhar Venkatesh, General Manager and President
    Registration: 60 of 63 (2023-12-31 to 2024-02-13)
    Posted: 2024-01-16
    Subject matter details: 18
    Government institutions: 16
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 10
  5. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Sridhar Venkatesh, General Manager and President
    Registration: 59 of 63 (2023-12-12 to 2023-12-31)
    Posted: 2023-12-14
    Subject matter details: 18
    Government institutions: 16
    Communication techniques: 2
    Government funding: Yes
    Employees who lobby: 10
  6. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Sridhar Venkatesh, General Manager and President
    Registration: 58 of 63 (2023-11-01 to 2023-12-12)
    Posted: 2023-12-07
    Subject matter details: 18
    Government institutions: 15
    Communication techniques: 2
    Government funding: Yes
    Employees who lobby: 12
  7. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Sridhar Venkatesh, General Manager and President
    Registration: 57 of 63 (2023-08-21 to 2023-11-01)
    Posted: 2023-08-21
    Subject matter details: 18
    Government institutions: 12
    Communication techniques: 2
    Government funding: Yes
    Employees who lobby: 12
  8. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Sridhar Venkatesh, General Manager and President
    Registration: 56 of 63 (2023-07-11 to 2023-08-21)
    Posted: 2023-07-11
    Subject matter details: 18
    Government institutions: 11
    Communication techniques: 2
    Government funding: Yes
    Employees who lobby: 12
  9. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Sridhar Venkatesh, General Manager and President
    Registration: 55 of 63 (2023-06-02 to 2023-07-11)
    Posted: 2023-06-02
    Subject matter details: 18
    Government institutions: 11
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 11
  10. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Sridhar Venkatesh, General Manager and President
    Registration: 54 of 63 (2023-01-26 to 2023-06-02)
    Posted: 2023-03-31
    Subject matter details: 18
    Government institutions: 12
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 10
  11. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Sridhar Venkatesh, General Manager and President
    Registration: 53 of 63 (2022-12-01 to 2023-01-26)
    Posted: 2022-12-02
    Subject matter details: 18
    Government institutions: 12
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 10
  12. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Zach Gana, Interim President and Senior Finance Director
    Registration: 51 of 63 (2022-11-23 to 2022-11-23)
    Posted: 2022-11-24
    Subject matter details: 18
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 10
  13. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Zach Gana, Interim President and Senior Finance Director
    Registration: 52 of 63 (2022-11-23 to 2022-12-01)
    Posted: 2022-11-28
    Subject matter details: 18
    Government institutions: 12
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 10
  14. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Zach Gana, Interim President and Senior Finance Director
    Registration: 50 of 63 (2022-09-06 to 2022-11-23)
    Posted: 2022-09-06
    Subject matter details: 16
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 10
  15. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Zach Gana, Interim President and Senior Finance Director
    Registration: 49 of 63 (2022-07-18 to 2022-09-06)
    Posted: 2022-07-26
    Subject matter details: 16
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 9
  16. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Faris El-Refaie, President
    Registration: 48 of 63 (2022-02-16 to 2022-07-18)
    Posted: 2022-02-16
    Subject matter details: 16
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 10
  17. Baylis Medical Company Inc.
    Type: Consultant
    Lobbyist: Emily Beduz, Santis Health
    Registration: 1 of 1 (2018-04-16 to 2018-09-21)
    Posted: 2018-04-18
    Subject matter details: 1
    Government institutions: 2
    Communication techniques: 2
    Government funding: No

Date Modified: